Low Frequency of Allelic Loss in Skin Tumours from Immunosuppressed Individuals
Author Information
Author(s): I Rehman, AG Quinn, M Takata, AEM Taylor, JL Rees
Primary Institution: Department of Dermatology, University of Newcastle upon Tyne, Newcastle upon Tyne, UK
Hypothesis
Tumours from immunosuppressed individuals have a different molecular pathogenesis compared to those from immunocompetent individuals.
Conclusion
Tumours in immunosuppressed individuals show a significantly lower rate of loss of heterozygosity than those in immunocompetent individuals.
Supporting Evidence
- Immunosuppressed individuals had a lower rate of loss of heterozygosity in their tumours compared to immunocompetent individuals.
- 20 out of 148 tumours from immunosuppressed individuals showed loss of heterozygosity, compared to 157 out of 428 in immunocompetent individuals.
- The study suggests a different molecular pathogenesis for tumours in immunosuppressed patients.
Takeaway
People who have received organ transplants and take medicine to suppress their immune system have different skin cancer tumors than those who don't.
Methodology
The study compared the rate of loss of heterozygosity in skin tumours from immunosuppressed patients and immunocompetent individuals using DNA analysis.
Participant Demographics
12 immunosuppressed patients (organ transplant recipients) and 68 immunocompetent individuals.
Statistical Information
P-Value
0.0001
Statistical Significance
p<0.0001
Want to read the original?
Access the complete publication on the publisher's website